Functions, divergence and clinical value of TAp73 isoforms in cancer.
about
Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73.PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cellsEmerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression.A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.The dominant-negative interplay between p53, p63 and p73: A family affair.Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs
P2860
Functions, divergence and clinical value of TAp73 isoforms in cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Functions, divergence and clinical value of TAp73 isoforms in cancer.
@en
type
label
Functions, divergence and clinical value of TAp73 isoforms in cancer.
@en
prefLabel
Functions, divergence and clinical value of TAp73 isoforms in cancer.
@en
P2093
P2860
P1476
Functions, divergence and clinical value of TAp73 isoforms in cancer
@en
P2093
Borek Vojtesek
Sotiris Galtsidis
Stella Logotheti
Vassilis Zoumpourlis
P2860
P2888
P304
P356
10.1007/S10555-013-9424-X
P577
2013-12-01T00:00:00Z
P6179
1019218787